Instituto Regional de Enfermedades Neoplasicas - IREN Norte
About Instituto Regional de Enfermedades Neoplasicas - IREN Norte
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
3
Clinical Trials at Instituto Regional de Enfermedades Neoplasicas - IREN Norte
During the past decade, Instituto Regional de Enfermedades Neoplasicas - IREN Norte conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Taselisib + Fulvestrant Versus Placebo + Fulvestrant in Participants With Advanced or Metastatic Breast Cancer Who Have Disease Recurrence or Progression During or After Aromatase Inhibitor Therapy
2015-04-09
2021-06-29
Terminated
631
A Study of Ipatasertib in Combination With Paclitaxel as a Treatment for Participants With PIK3CA/AKT1/PTEN-Altered, Locally Advanced or Metastatic, Triple-Negative Breast Cancer or Hormone Receptor-Positive, HER2-Negative Breast Cancer
2018-01-06
2023-01-04
Completed
580
A Study Evaluating the Efficacy and Safety of Giredestrant Combined With Palbociclib Compared With Letrozole Combined With Palbociclib in Participants With Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (persevERA Breast Cancer)
2020-10-09
2027-03-18
Active, not recruiting
992
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Instituto Regional de Enfermedades Neoplasicas - IREN Norte
According to Clinical.Site data, the most researched conditions in "Instituto Regional de Enfermedades Neoplasicas - IREN Norte" are
"Breast Cancer" (2 trials) and "Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "Instituto Regional de Enfermedades Neoplasicas - IREN Norte" in a lesser frequency.
Clinical Trials Intervention Types at Instituto Regional de Enfermedades Neoplasicas - IREN Norte
Most popular intervention types in "Instituto Regional de Enfermedades Neoplasicas - IREN Norte" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "Fulvestrant" (1 trials), "Giredestrant" (1 trials), "Giredestrant-matched Placebo" (1 trials) and "Ipatasertib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Instituto Regional de Enfermedades Neoplasicas - IREN Norte
The vast majority of trials in "Instituto Regional de Enfermedades Neoplasicas - IREN Norte" are
2 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Instituto Regional de Enfermedades Neoplasicas - IREN Norte
Currently, there are NaN active trials in "Instituto Regional de Enfermedades Neoplasicas - IREN Norte".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Instituto Regional de Enfermedades Neoplasicas - IREN Norte,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Instituto Regional de Enfermedades Neoplasicas - IREN Norte, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".